Type 2 Diabetes Treated With Insulin Clinical Trial
Official title:
The Diabetes teleMonitoring of Patients in Insulin Therapy (DiaMonT) Trial: Study Protocol for a Randomized Controlled Trial
The trial is an open-label randomized controlled trial. Patients with T2D on insulin therapy will be randomized to a telemonitoring group (intervention) and a usual care group (control). The telemonitoring group will use various devices at home. Hospital staff will monitor their data for a period of three months.
The DiaMonT trial is an open-label randomized controlled trial with a trial period of three months conducted. The trial will be conducted in two sites in Denmark: Steno Diabetes Center North Jutland and Steno Diabetes Center Zealand. Patients with T2D on insulin therapy will be randomized (1:1) to a telemonitoring group (intervention) or a usual care group (control). The telemonitoring group will use an insulin pen, an activity tracker, a CGM, and a smartphone application throughout the trial period. Hospital staff (lab technicians and nurses) will monitor the telemonitoring groups' data and contact the subjects by telephone repeatedly throughout the trial period. The usual care group will use a blinded CGM the first and last 20 days of the trial and will use a blinded insulin pen for the entire period. The usual care groups' data will not be monitored during the trial. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04522882 -
Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1
|
N/A | |
Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
Not yet recruiting |
NCT05185518 -
Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05893797 -
A Study of LY8888AX in Participants Using a Connected Insulin Management Platform
|
N/A | |
Completed |
NCT02791295 -
Lifestyle Intervention in Type 2 Diabetes
|
N/A | |
Withdrawn |
NCT04957173 -
Intensive Lifestyle Intervention in Patients With Insulin-treated Type 2 Diabetes: a Pilot Project
|
N/A | |
Not yet recruiting |
NCT05317585 -
Continuous Glucose Monitor Use in Pregnancy
|
N/A | |
Completed |
NCT05372471 -
Efficacy of the Digital Platform for Diabetes Care Compared to Usual Care in Patients Diagnosed With Type 2 Diabetes.
|
N/A | |
Completed |
NCT05111301 -
Control-IQ Technology in Individuals With Type 2 Diabetes
|
N/A | |
Active, not recruiting |
NCT04585191 -
Reducing Treatment Risk in Older Adults With Diabetes
|
N/A | |
Recruiting |
NCT04871438 -
Flash CONtinous Glucose Monitoring in TRansition to Outpatient: Libre for Type 2 Diabetes Mellitus (CONTROL-DM)
|
N/A | |
Completed |
NCT06060743 -
Examining the Effect of Mobile Application on Insulin Use Perception and Self-Management
|
N/A | |
Completed |
NCT04005261 -
C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes
|
||
Terminated |
NCT03980236 -
Feasibility of Using the Livongo-Insulia Study App for Patients With Type 2 Diabetes [Pilot Study]
|
N/A | |
Not yet recruiting |
NCT06185296 -
The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy
|
N/A | |
Completed |
NCT03437525 -
Peer Support in Diabetes Management - Insulin Peer Support
|
N/A | |
Active, not recruiting |
NCT03070106 -
Diabetes: Functional Medicine Approach vs. Usual Care
|
N/A | |
Completed |
NCT02060916 -
Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT05785832 -
A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT04945070 -
INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi
|
Phase 4 |